Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: a systematic review and meta-analysis.


Journal

Perfusion
ISSN: 1477-111X
Titre abrégé: Perfusion
Pays: England
ID NLM: 8700166

Informations de publication

Date de publication:
Jul 2021
Historique:
pubmed: 31 8 2020
medline: 25 11 2021
entrez: 1 9 2020
Statut: ppublish

Résumé

The purpose was to compare time-based vs anti-Xa-based anticoagulation strategies in patients on ECMO. We conducted a systematic review and meta-analysis using multiple electronic databases and included studies from inception to July 19, 2019. The proportion of bleeding, thrombosis, and mortality were evaluated.Twenty-six studies (2,086 patients) were included. Bleeding occurred in 34.2% (95%CI 25.1;43.9) of the patients with anti-Xa-based versus 41.6% (95%CI 24.9;59.4) of the patients with time-based anticoagulation strategies. Thrombosis occurred in 32.6% (95%CI 19.1;47.7) of the patients with anti-Xa-based versus 38.4% (95%CI 22.2;56.1) of the patients with time-based anticoagulation strategies. And mortality rate was 35.4% (95%CI 28.9;42.1) of the patients with anti-Xa-based versus 42.9% (95%CI 36.9;48.9) of the patients with time-based anticoagulation strategies. Among the seven studies providing results from both anticoagulation strategies, significantly fewer bleeding events occurred in the anti-Xa-based anticoagulation strategy (adjusted OR 0.49 (95%CI 0.32;0.74),

Identifiants

pubmed: 32862767
doi: 10.1177/0267659120952982
pmc: PMC8216320
doi:

Substances chimiques

Anticoagulants 0
Heparin 9005-49-6

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

501-512

Commentaires et corrections

Type : CommentIn

Références

J Cardiothorac Vasc Anesth. 2020 Jan;34(1):192-207
pubmed: 31679998
Perfusion. 2017 Oct;32(7):538-546
pubmed: 28466677
Ann Am Thorac Soc. 2016 Dec;13(12):2242-2250
pubmed: 27690525
Ann Intern Med. 2013 Feb 19;158(4):280-6
pubmed: 23420236
Pediatr Crit Care Med. 2017 Nov;18(11):1055-1062
pubmed: 28922263
Lancet. 2000 Oct 7;356(9237):1228-31
pubmed: 11072941
BMJ. 2011 Jul 22;343:d4002
pubmed: 21784880
Crit Care Med. 2019 Jul;47(7):e563-e571
pubmed: 31033512
Pediatr Crit Care Med. 2015 Jan;16(1):66-74
pubmed: 25319630
Ann Intern Med. 1997 Nov 1;127(9):820-6
pubmed: 9382404
Semin Cardiothorac Vasc Anesth. 2009 Sep;13(3):154-75
pubmed: 19767408
Crit Care. 2020 Jan 20;24(1):19
pubmed: 31959232
Pediatr Crit Care Med. 2014 Jun;15(5):e198-205
pubmed: 24614609
J Crit Care. 2017 Jun;39:87-96
pubmed: 28237895
Contemp Clin Trials. 2007 Feb;28(2):105-14
pubmed: 16807131
ASAIO J. 2019 Mar/Apr;65(3):270-276
pubmed: 29746314
Minerva Anestesiol. 2016 Aug;82(8):858-66
pubmed: 27050286
Pediatr Crit Care Med. 2019 Nov;20(11):1034-1039
pubmed: 31517728
J Extra Corpor Technol. 2018 Mar;50(1):30-37
pubmed: 29559752
Anesthesiology. 2020 Mar;132(3):562-570
pubmed: 31764152
ASAIO J. 2015 May-Jun;61(3):339-44
pubmed: 25710768
ASAIO J. 2020 Mar;66(3):307-313
pubmed: 30883406
ASAIO J. 2017 Nov/Dec;63(6):793-801
pubmed: 28678046
Pediatr Crit Care Med. 2014 Feb;15(2):e72-9
pubmed: 24335992
Front Med (Lausanne). 2018 Dec 12;5:352
pubmed: 30619862
Anesth Analg. 2013 Jun;116(6):1210-22
pubmed: 23408671
ASAIO J. 2020 Mar;66(3):300-306
pubmed: 31045921
ASAIO J. 2014 Jan-Feb;60(1):57-62
pubmed: 24296776
Perfusion. 2017 Nov;32(8):675-685
pubmed: 28693359
Expert Rev Respir Med. 2012 Aug;6(4):377-84
pubmed: 22971063
ASAIO J. 2021 Feb 1;67(2):196-200
pubmed: 33512915
Perfusion. 2014 Sep;29(5):456-61
pubmed: 24570077
Thromb Res. 2019 Jul;179:132-139
pubmed: 31132667
Nurs Res. 2003 Jul-Aug;52(4):256-61
pubmed: 12867783
ASAIO J. 2013 Jan-Feb;59(1):63-8
pubmed: 23263338
Am J Respir Crit Care Med. 2017 Sep 15;196(6):762-771
pubmed: 28328243
J Extra Corpor Technol. 2018 Sep;50(3):149-154
pubmed: 30250340
Pediatr Crit Care Med. 2014 May;15(4):e175-82
pubmed: 24622165
Arch Surg. 2000 Sep;135(9):1042-7
pubmed: 10982508
Am J Cardiovasc Drugs. 2017 Dec;17(6):425-439
pubmed: 28536932
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Pediatr Crit Care Med. 2013 Feb;14(2):e77-84
pubmed: 23287906
J Epidemiol Community Health. 2013 Nov 1;67(11):974-8
pubmed: 23963506

Auteurs

Ariane Willems (A)

Pediatric Critical Care Medicine, Department of Intensive Care, Leiden University Medical Center, Leiden, The Netherlands.

Peter P Roeleveld (PP)

Pediatric Critical Care Medicine, Department of Intensive Care, Leiden University Medical Center, Leiden, The Netherlands.

Sonia Labarinas (S)

Department of Pediatrics, Section of Critical Care Medicine, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.

John W Cyrus (JW)

Tompkins-McCaw Library for the Health Sciences, VCU Libraries, Virginia Commonwealth University, Richmond, VA, USA.

Jennifer A Muszynski (JA)

Division of Critical Care Medicine, Nationwide Children's Hospital, Columbus, OH, USA.

Marianne E Nellis (ME)

Pediatric Critical Care Medicine, Department of Pediatrics, NY Presbyterian Hospital - Weill Cornell Medicine, New York, NY, USA.

Oliver Karam (O)

Division of Pediatric Critical Care Medicine, Children's Hospital of Richmond at VCU, Richmond, VA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH